187 related articles for article (PubMed ID: 23840565)
1. RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43.
Takagi S; Iguchi Y; Katsuno M; Ishigaki S; Ikenaka K; Fujioka Y; Honda D; Niwa J; Tanaka F; Watanabe H; Adachi H; Sobue G
PLoS One; 2013; 8(6):e66966. PubMed ID: 23840565
[TBL] [Abstract][Full Text] [Related]
2. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
3. Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination.
Dammer EB; Fallini C; Gozal YM; Duong DM; Rossoll W; Xu P; Lah JJ; Levey AI; Peng J; Bassell GJ; Seyfried NT
PLoS One; 2012; 7(6):e38658. PubMed ID: 22761693
[TBL] [Abstract][Full Text] [Related]
4. TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA.
Che MX; Jiang LL; Li HY; Jiang YJ; Hu HY
FEBS Lett; 2015 Jul; 589(15):1920-8. PubMed ID: 26099433
[TBL] [Abstract][Full Text] [Related]
5. Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site.
Furukawa Y; Kaneko K; Nukina N
Biochim Biophys Acta; 2011 Dec; 1812(12):1577-83. PubMed ID: 21946215
[TBL] [Abstract][Full Text] [Related]
6. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43.
Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M
PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771
[TBL] [Abstract][Full Text] [Related]
7. [The molecular mechanisms of intracellular TDP-43 aggregates].
Nonaka T; Arai T; Hasegawa M
Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
Hans F; Eckert M; von Zweydorf F; Gloeckner CJ; Kahle PJ
J Biol Chem; 2018 Oct; 293(41):16083-16099. PubMed ID: 30120199
[TBL] [Abstract][Full Text] [Related]
9. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.
Zhang YJ; Xu YF; Cook C; Gendron TF; Roettges P; Link CD; Lin WL; Tong J; Castanedes-Casey M; Ash P; Gass J; Rangachari V; Buratti E; Baralle F; Golde TE; Dickson DW; Petrucelli L
Proc Natl Acad Sci U S A; 2009 May; 106(18):7607-12. PubMed ID: 19383787
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
[TBL] [Abstract][Full Text] [Related]
11. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1.
Brady OA; Meng P; Zheng Y; Mao Y; Hu F
J Neurochem; 2011 Jan; 116(2):248-59. PubMed ID: 21062285
[TBL] [Abstract][Full Text] [Related]
12. The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates.
Wang YT; Kuo PH; Chiang CH; Liang JR; Chen YR; Wang S; Shen JC; Yuan HS
J Biol Chem; 2013 Mar; 288(13):9049-57. PubMed ID: 23372158
[TBL] [Abstract][Full Text] [Related]
13. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.
Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM
J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
[TBL] [Abstract][Full Text] [Related]
15. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains.
Seyfried NT; Gozal YM; Dammer EB; Xia Q; Duong DM; Cheng D; Lah JJ; Levey AI; Peng J
Mol Cell Proteomics; 2010 Apr; 9(4):705-18. PubMed ID: 20047951
[TBL] [Abstract][Full Text] [Related]
16. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.
Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA
J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641
[TBL] [Abstract][Full Text] [Related]
17. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies.
Iguchi Y; Katsuno M; Takagi S; Ishigaki S; Niwa J; Hasegawa M; Tanaka F; Sobue G
Neurobiol Dis; 2012 Mar; 45(3):862-70. PubMed ID: 22198567
[TBL] [Abstract][Full Text] [Related]
19. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.
Romano V; Quadri Z; Baralle FE; Buratti E
Prion; 2015; 9(1):1-9. PubMed ID: 25635624
[TBL] [Abstract][Full Text] [Related]
20. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.
Nishimoto Y; Ito D; Yagi T; Nihei Y; Tsunoda Y; Suzuki N
J Biol Chem; 2010 Jan; 285(1):608-19. PubMed ID: 19887443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
